Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Sep 6, 2018--Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Frank D’Amelio, Executive Vice President, Business Operations, and Chief Financial Officer, at the Morgan Stanley 16 th Annual Global Healthcare Conference on Thursday, September 13, 2018 at 2:55 p.m. Eastern Daylight Time.
Visitors will be able to listen to an archived copy of the webcast at www.pfizer.com/investors.
Disclosure Notice: The webcast may include forward-looking statements about, among other things, our anticipated future operating and financial performance, business plans and prospects, in-line products and product candidates, strategic reviews, capital allocation, plans to organize our commercial operations into three businesses effective at the beginning of the company’s 2019 fiscal year, business-development plans, the benefits expected from our business development transactions and plans relating to share repurchases and dividends that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at and .
The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005684/en/
CONTACT: Pfizer Inc.
Joan Campion, 212-733-2798
Ryan Crowe, 212-733-8160
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL RESEARCH OTHER SCIENCE SCIENCE GENERAL HEALTH
SOURCE: Pfizer Inc.
Copyright Business Wire 2018.
PUB: 09/06/2018 11:30 AM/DISC: 09/06/2018 11:30 AM